Alpha Teknova, Inc. (NASDAQ:TKNO) Stock Now Rated “Moderate Buy” by Sell-Side Brokerages

Alpha Teknova, Inc. (NASDAQ:TKNO) has been assigned an average rating of “Moderate Buy” from the six analysts that are presently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and four have assigned a buy rating to the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $8.75.

Several brokerages have recently issued reports on TKNO. Weiss Ratings lowered Alpha Teknova from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Tuesday, August 11th. BTIG Research upgraded Alpha Teknova from a “neutral” rating to a “buy” rating and set a $8.00 price objective for the company in a research report on Tuesday, August 11th. Jefferies Financial Group assumed coverage on Alpha Teknova in a research report on Thursday, September 17th. They set a “buy” rating and a $9.00 price objective for the company. Roth Capital began coverage on Alpha Teknova in a research note on Wednesday, August 5th. They issued a “buy” rating and a $7.00 price objective on the stock. Finally, Zacks Research raised Alpha Teknova to a “hold” rating in a research note on Thursday, August 6th.

Alpha Teknova Stock Performance

NASDAQ TKNO opened at $7.08 on Monday. The firm’s 50 day simple moving average is $7.74 and its 200 day simple moving average is $5.58. The firm has a market capitalization of $379.56 million, a price-to-earnings ratio of -22.84 and a beta of 0.85. The company has a current ratio of 4.49, a quick ratio of 3.48 and a debt-to-equity ratio of 0.21. Alpha Teknova has a 1 year low of $1.91 and a 1 year high of $9.48.

Alpha Teknova (NASDAQ:TKNO) last announced its quarterly earnings data on Wednesday, August 5th. The company reported ($0.06) EPS for the quarter, beating the consensus estimate of ($0.08) by $0.02. Alpha Teknova had a negative net margin of 38.37% and a negative return on equity of 24.94%. The business had revenue of $12.19 million during the quarter, compared to the consensus estimate of $10.95 million. As a group, research analysts expect that Alpha Teknova will post -0.28 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Susquehanna International Group LLP acquired a new stake in shares of Alpha Teknova in the 2nd quarter valued at approximately $115,000. Bank of America Corp DE bought a new stake in shares of Alpha Teknova during the 2nd quarter valued at approximately $1,453,000. Ieq Capital LLC acquired a new position in Alpha Teknova during the 2nd quarter worth approximately $62,000. BlackRock Inc. acquired a new position in Alpha Teknova during the 2nd quarter worth approximately $4,997,000. Finally, Deutsche Bank AG acquired a new position in Alpha Teknova during the 2nd quarter worth approximately $62,000. Institutional investors own 13.81% of the company’s stock.

About Alpha Teknova

Alpha Teknova, Inc develops and manufactures critical reagents and process solutions used in life sciences research, biopharmaceutical production, cell and gene therapies, vaccines, and molecular diagnostics. The company serves customers that require specialized materials for developing, scaling, and commercializing biological products.

Its product portfolio includes research-grade and current good manufacturing practice (cGMP) buffers, reagents, media, and other process fluids. Alpha Teknova also provides custom formulation, development, manufacturing, and packaging services designed to support applications ranging from laboratory research to regulated commercial production.

Founded in 1996 and headquartered in Hollister, California, Alpha Teknova serves biotechnology, pharmaceutical, diagnostic, academic, and research customers.